Rysä, J <br/><br/>
Pregnane X receptor agonists impair postprandial glucose tolerance.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Jun 2013 
 - 556-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2013.48  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>C-Peptide--metabolism<br/>Cross-Over Studies<br/>Down-Regulation--drug effects<br/>Female<br/>Glucose Tolerance Test--statistics & numerical data<br/>Glucose Transporter Type 2--biosynthesis<br/>Humans<br/>Insulin--metabolism<br/>Insulin Resistance<br/>Liver--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Postprandial Period<br/>Pregnane X Receptor<br/>Pregnenolone Carbonitrile--pharmacology<br/>Primary Cell Culture<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Steroid--agonists<br/>Rifampin--pharmacology